Articles

What does an ambitious contract manufacturer need when customers wish to expand their orders? Exactly, new equipment! The Malmö-based Swedish company Rechon has been a reliable partner to many pharmaceutical producers for decades, from...

The growing interest in genomic research, personalized medicine and ribonucleic acid (RNA)-based therapies is fueling demand for high quality oligonucleotides. RNA is a biological molecule that plays a crucial role in the transfer of genetic...

The industry is using lessons learned during, to help eliminate underlying healthcare vulnerabilities and improve speed and efficiency of relief efforts The COVID-19 pandemic is often described as a “once-in-a-century” event. Yet, although the virus...

As of January 31, 2022, the EU has implemented the Regulation 2014/536 on clinical trials for Medicinal Products (MPs) intended for human use. This regulation provides a centralized approach for electronic submission and evaluation...

Decentralized clinical trials (DCTs) can be considered to be the future of the industry due to the benefits they provide to drug developers and patients and their growing popularity. These benefits include ease for...

In pharmaceutical world, Forecasting and market research is an art or science or rather in between. Oxford dictionary describes forecasting as “a statement about what will happen in the future, based on information that...

Enhancing Data Infrastructure in Manufacturing with Process Analytical Technologies (PAT) Securing product quality during manufacturing is essential for the safety and efficacy of the end bioproduct. Improved understanding of manufacturing processes can enhance transparency and...

The biopharmaceutical industry faces a future shaped by uncertainty in the wake of the pandemic-influenced world, yet overall growth is expected to continue. The Pharmaceutical Manufacturing Market Size Report states that the market will...

As 2023 takes over, there is a lot of hope that makes us cling to the pharmaceutical sector: a hope of getting novel ideas to work, a hope to embrace more technology, and a hope to...

Eric Hsu, Account Director of Alliance Management at Samsung Biologics, examines how we can apply the lessons of the COVID-19 pandemic to the biopharma industry in future. He also explores the ongoing trends in...